These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9238143

  • 1. A Canadian hospital-based HIV/hepatitis C look-back notification program.
    Heddle N, Kelton JG, Smaill F, Foss K, Everson J, Janzen C, Walker C, Jones M, Hammons D.
    CMAJ; 1997 Jul 15; 157(2):149-54. PubMed ID: 9238143
    [Abstract] [Full Text] [Related]

  • 2. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH, Jacob J, Homan CE, Williams JL, Christensen CJ, McMahon BJ.
    Arch Pediatr Adolesc Med; 2007 Feb 15; 161(2):125-30. PubMed ID: 17283296
    [Abstract] [Full Text] [Related]

  • 3. Blood recipient notification for hepatitis C in Prince Edward Island.
    Van Til LD, Sweet LE.
    CMAJ; 2000 Jan 25; 162(2):199-202. PubMed ID: 10674052
    [Abstract] [Full Text] [Related]

  • 4. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL, Cagle HH, Christensen CJ, Fox-Leyva LK, McMahon BJ.
    Transfusion; 2005 Jun 25; 45(6):1020-6. PubMed ID: 15935002
    [Abstract] [Full Text] [Related]

  • 5. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
    Zeiler T, Kretschmer V, Sibrowski W.
    Infusionsther Transfusionsmed; 1994 Dec 25; 21(6):362-7. PubMed ID: 7873914
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM, González-Velázquez F, González-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martínez-Rodríguez ML, Cortés-Márquez SR, Blanco-Flores JP, Rodríguez-Rodríguez A, Del Campo MA, Cortés-Gómez R, Mejía-Bocanegra MG.
    Transfusion; 2009 Oct 25; 49(10):2200-7. PubMed ID: 19538543
    [Abstract] [Full Text] [Related]

  • 7. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Aug 24; 72(164):48765-801. PubMed ID: 17886394
    [Abstract] [Full Text] [Related]

  • 8. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
    Whitlock M, Lord S, Buxton JA, Doyle P, Bigham M.
    Transfusion; 2007 Aug 24; 47(8):1534-9. PubMed ID: 17655599
    [Abstract] [Full Text] [Related]

  • 9. Maintaining confidentiality in a look-back investigation of patients treated by a HIV-infected dentist.
    Arnow PM, Chou T, Shapiro R, Sussman EJ.
    Public Health Rep; 1993 Aug 24; 108(3):273-8. PubMed ID: 8497563
    [Abstract] [Full Text] [Related]

  • 10. Look-back study of Hepatitis C in teenagers after blood transfusions as neonates.
    Kori M, Flidel-Rimon O, Sigler E, Shinwell E, Granot E.
    Acta Paediatr; 2007 Jul 24; 96(7):1050-2. PubMed ID: 17498189
    [Abstract] [Full Text] [Related]

  • 11. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA.
    P N G Med J; 1996 Mar 24; 39(1):38-42. PubMed ID: 9522849
    [Abstract] [Full Text] [Related]

  • 12. Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: theoretical risk for real people.
    King SM, Watson H, Heurter H, Ricketts M, Elsaadany S.
    CMAJ; 1998 Oct 06; 159(7):771-4. PubMed ID: 9805022
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH, Murad S, Easterbrook PJ.
    HIV Med; 2005 May 06; 6(3):206-15. PubMed ID: 15876288
    [Abstract] [Full Text] [Related]

  • 14. Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population.
    Akhter J, Roberts GT, Perry A, Gaucher JS, Howman PA.
    Saudi Med J; 2001 Dec 06; 22(12):1073-5. PubMed ID: 11802179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Azarow K, Holcomb JB, 31st Combat Support Hospital Research Working Group.
    Crit Care Med; 2007 Nov 06; 35(11):2576-81. PubMed ID: 17828033
    [Abstract] [Full Text] [Related]

  • 17. Use of blood donation history of people with HIV infection to identify recipients at risk.
    Gill MJ, Meyers G, Rajwani A.
    CMAJ; 1994 Oct 15; 151(8):1147-51. PubMed ID: 7922946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
    Gerner P, Wirth S, Wintermeyer P, Walz A, Jenke A.
    J Infect; 2006 Apr 15; 52(4):305-8. PubMed ID: 16473408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.